sb 203580 has been researched along with eht 1864 in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (eht 1864) | Trials (eht 1864) | Recent Studies (post-2010) (eht 1864) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 36 | 0 | 30 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kowluru, A; Sidarala, V | 1 |
1 other study(ies) available for sb 203580 and eht 1864
Article | Year |
---|---|
Exposure to chronic hyperglycemic conditions results in Ras-related C3 botulinum toxin substrate 1 (Rac1)-mediated activation of p53 and ATM kinase in pancreatic β-cells.
Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Imidazoles; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Morpholines; p38 Mitogen-Activated Protein Kinases; Prenylation; Pyridines; Pyrones; Quinolines; rac1 GTP-Binding Protein; Rats; Simvastatin; Tumor Suppressor Protein p53 | 2017 |